About Seoul Medical Center
서울특별시 서울의료원은 서울특별시 중랑구 신내로 156 에 위치한 서울특별시 산하 시립 종합병원이다. 지역거점공공병원, 권역응급의료센터로 지정되어 있다.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Seoul Medical Center
5
HK inno.N Corporation
3
Pfizer
3
Asan Medical Center
2
Gilead Sciences
2
Shin Poong Pharmaceutical Co. Ltd.
2
Boehringer Ingelheim
1
Bukwang Pharmaceutical
1
Celgene
1
Chong Kun Dang Pharmaceutical
1
Clinical Research Center for End Stage Renal Disease, Korea
1
Clinical Trials at Seoul Medical Center
During the past decade, Seoul Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on
average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV
2012-03-02
2016-05-20
Completed
244
Mode of Dialysis Therapy and Outcomes in End Stage Renal Disease (ESRD)
2009-07-01
2023-12-01
Active, not recruiting
5,400
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
2009-06-01
2016-12-01
Unknown status
1,600
Exelon Patch and Combination With Memantine Comparative Trial
2008-12-01
2010-04-01
Completed
206
Comparison of the Effect Between Levofloxacin and Moxifloxacin Among MDR-TB Patients
2010-03-01
2012-10-01
Terminated
182
Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis
2010-04-01
2015-12-01
Terminated
132
A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
2010-10-01
2014-10-01
Completed
767
The Bupivacaine Dose Sparing Effect of Intrathecal Epinephrine
2010-12-01
2011-07-01
Completed
75
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Seoul Medical Center" #1 sponsor was "Seoul Medical Center" with 5 trials, followed by "HK inno.N Corporation" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Asan Medical Center" with 2 trials sponsored and "Gilead Sciences"
with 2 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul Medical Center"
#1 collaborator was "Daiichi Sankyo Korea Co., Ltd." with 2 trials as a collaborator, "Asan Medical Center" with 1 trials as a collaborator, "Daegu Metropolitan City, Korea" with 1 trials as a collaborator, "Korea Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator and "Kyungpook National University Hospital" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Seoul Medical Center
According to Clinical.Site data, the most researched conditions in "Seoul Medical Center" are
"COVID-19" (6 trials), "Essential Hypertension" (3 trials), "Brain Ischemia" (2 trials), "General Anesthesia" (2 trials) and "Laparoscopic Cholecystectomy" (2 trials). Many other conditions were trialed in "Seoul Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Seoul Medical Center
Most popular intervention types in "Seoul Medical Center" are "Drug" (26 trials), "Device" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Amlodipine 10mg, Candesartan cilexetil 16mg" (2 trials), "Amlodipine 5mg" (2 trials), "Candesartan cilexetil 16mg" (2 trials) and "Remdesivir" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Seoul Medical Center
The vast majority of trials in "Seoul Medical Center" are
31 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Seoul Medical Center
Currently, there are NaN active trials in "Seoul Medical Center".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in Seoul Medical Center,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Seoul Medical Center, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 5 trials that are defined as “Not Applicable".